Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fortum Corporation: Managers' transactions – Veli-Matti Reinikkala

FORTUM CORPORATION STOCK EXCHANGE RELEASE 24 MAY 2022 AT 13:30 EEST Release category: Managers’ transactions Person subject to the notification requirement Name: Reinikkala, Veli-Matti Position: Member of the Board/Deputy member Issuer: Fortum Corporation LEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATION Reference number: 635400IUIZZIUJSAMF76_20220524091713_163 Transaction date: 2022-05-23 Venue: XHEL Instrument type: SHARE ISIN: FI0009007132 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

Fortum Corporation: Managers' transactions – Teppo Paavola

FORTUM CORPORATION STOCK EXCHANGE RELEASE 24 MAY 2022 AT 13:30 EEST Release category: Managers’ transactions Person subject to the notification requirement Name: Paavola, Teppo Position: Member of the Board/Deputy member Issuer: Fortum Corporation LEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATION Reference number: 635400IUIZZIUJSAMF76_20220524091713_162 Transaction date: 2022-05-23 Venue: XHEL Instrument type: SHARE ISIN: FI0009007132 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume:

Fortum Corporation: Managers' transactions – Luisa Delgado

FORTUM CORPORATION STOCK EXCHANGE RELEASE 24 MAY 2022 AT 13:30 EEST Release category: Managers’ transactions Person subject to the notification requirement Name: Delgado, Luisa Position: Member of the Board/Deputy member Issuer: Fortum Corporation LEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATION Reference number: 635400IUIZZIUJSAMF76_20220524091713_159 Transaction date: 2022-05-23 Venue: XHEL Instrument type: SHARE ISIN: FI0009007132 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume:

Fortum Corporation: Managers' transactions – Ralf Christian

FORTUM CORPORATION STOCK EXCHANGE RELEASE 24 MAY 2022 AT 13:30 EEST Release category: Managers’ transactions Person subject to the notification requirement Name: Christian, Ralf Position: Member of the Board/Deputy member Issuer: Fortum Corporation LEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATION Reference number: 635400IUIZZIUJSAMF76_20220524091713_166 Transaction date: 2022-05-23 Venue: XHEL Instrument type: SHARE ISIN: FI0009007132 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1): Volume:

Bulletin from the Annual General Meeting in IRRAS AB (publ) on 24 May 2022

The Annual General Meeting in IRRAS AB (publ) has been held on 24 May 2022 and in particular the following decisions were resolved. The Annual General Meeting resolved to adopt the balance sheet, income statement, consolidated income statement and consolidated balance sheet for 2021. Furthermore, it was resolved that no dividend will be distributed and disposable profits as of 31 December 2021 are carried forward. The Annual General Meeting also resolved to discharge the board members and the CEO from liability for 2021. The Annual General Meeting approved the nominating committee'

Ingka Investments make minority Investment in Urban Jungle

Ingka Investments has made a financial minority Investment in a UK based insurance startup called Urban Jungle, who are a leading company in using technology to provide fair home Insurance to renters and homeowners. The investment is part of Urban Jungle’s latest funding round with investors contributing to a total of £16,5 million (€21,5m / $23m) of equity capital to accelerate its growth and rapidly scale its UK Home insurance business, as well expand in new markets.Founded in 2016, Urban Jungle is now one of the UK’s top-rated insurance providers, reaching the recent milestone of helping

Read original

Relais Group Plc has completed the acquisition of the Swedish company Skeppsbrons Jönköping AB and decided on the related share issue

Relais Group Plc, Company release 24 May 2022 at 1:00 p.m. EET Relais Group Plc (the "Company", "Relais"), the leading consolidator in the Nordic vehicle aftermarket, has completed the acquisition of the entire share capital of the Swedish Skeppsbrons Jönköping AB ("Skeppsbrons"), as announced on 5 May 2022. Skeppsbrons will be reported as part of the Relais Group as of 1 May 2022. The purchase price of the entire stock of Skeppsbrons was MSEK 87.6, of which MSEK 14.0 was paid by shares in Relais and MSEK 73.6 in cash. Relais paid the share component of the purchase price by

Knowit acquires the software engineering company Swedspot

Knowit AB is acquiring Swedspot, a company with a strong focus on software development for the car industry. The company has around 40 employees based in Gothenburg and Trollhättan. Swedspot will be an important addition to Knowit’s business area Connectivity, supplementing existing offers in embedded systems with both broad competence in software development and a unique platform with smart services for connected vehicles.Demand for modern, connected technology in industrial companies in general, and the car industry in particular, is high and growing, in step with an increasing degree of

Change to Citycon´s financial reporting schedule in 2022

CITYCON OYJ    Stock Exchange Release   24 May 2022 at 12:30 hrsCitycon Oyj amends its 2022 financial reporting schedule for its six-month Half-Yearly Report due to changed meeting schedule. Citycon will publish its six-month Half-Yearly Report on 10 August 2022 about 8:30 p.m. EEST (previously 13 July 2022 about 9:00 a.m. EEST). Citycon's investor, analyst and press conference call and live audiocast will be organized on 11 August 2022 at 10 a.m. EEST (previously 13 July 2022 at 10:00 EEST). Further information:Sakari JärveläVice President, Corporate Finance and Investor Relations

Inhalation Sciences AB secures long-term financing of operations

(Stockholm, Sweden, 24 May 2022) Inhalation Sciences AB has received a credit line from a consortium of lenders of up to SEK 10 million, giving the company increased scope to finance its operations and growth over the next 12-14 months.The company's chairman of the board, Daniel Spasic, is among the lenders through his American company S-Growth Capital LLC, with a loan of SEK 1 million. The company estimates that the credit line, together with self-generated funds, will be to sufficient to finance ISAB in line with its growth strategy for the coming 12-14 months. Daniel Spasic,

Saab Receives Swedish Order for Torpedo Tubes for Surface Ships

Saab has received an order from the Swedish Defence Materiel Administration for a new torpedo tube for lightweight torpedos. The order value is approximatly SEK 150 million, and there is an option to increase the quantity of the order. Deliveries will take place 2023-2024.The new torpedo tube will have the customer designation Tub m/20 in Sweden, and will replace the tube currently in use on the Swedish Navy’s corvettes. “The new torpedo tube will enhance and future proof Sweden’s capability for operating lightweight torpedoes from surface ships, thereby helping their anti-submarine

Investor AB to utilize mandate to repurchase shares

The Annual General Meeting of Investor 2022 authorized the company's Board to resolve on the purchase of the company’s own shares. The shares may be purchased in order to, among other things, secure the obligations and hedge the costs related to Investor's long-term variable remuneration program for employees within Investor and to the synthetic shares issued as part of the Board remuneration. Investor's Board has now decided to utilize the authorization for these purposes. The purchase of own shares may take place on Nasdaq Stockholm prior to June 15, 2022 at a price within the price

Repurchase of NCC Series B shares in week 20, 2022

During the period May 16 – May 20, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 421 752 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

The best Live Casino games in the UK

Live casino is one of the most popular and exciting areas of any online casino. It includes classics such as Blackjack, Roulette and Poker as well as quiz show influenced games that are instantly playable and fun.  The live part of the name comes from the fact that it’s played in real time, with real hosts, which gives the experience an immediacy that no other online casino games can match. With real hosts to interact with, this allows you to be immersed in the game like you would at any high-class casino, only you don’t even need to wear a tuxedo or fancy dress.Different types of Live

Alzinova publishes prospectus in connection with rights issue of units

Alzinova AB (publ) (“Alzinova” or the “Company”) has prepared an EU growth prospectus (the “Prospectus”) in connection with the rights issue of units consisting of shares and warrants which was announced through a press release on 19 April 2022 (the “Rights Issue”). The Prospectus has today been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen).NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND,

The Horizon 2020 project DeteCTCs initiates clinical study for development of next generation CTC-based cancer diagnostics

Stockholm, Sweden. May 24, 2022. iCellate Medical AB, in association with the University Medical Center Schleswig-Holstein and QIAGEN, Inc. are proud to announce that the clinical study portion of their joint project DeteCTCs, subsidized by the EU Horizon 2020 programme, has included its first study subject.We are excited to announce the enrollment of the first subject into the clinical study portion of the DeteCTCs project, to accelerate the continued development of iCellate’s next-generation CellMate[®] in vitro diagnostic platform. Over two years, this study will enroll approximately 260

NextCell invited to speak at Advance Therapies Congress in London

NextCell Pharma AB (“NextCell”) present the ongoing clinical trial program with the lead cell therapy drug candidate, ProTrans, at the Advanced Therapies Congress in London on May 24[th]-25[th]. The presentation will be given by NextCell’s CEO, Dr. Mathias Svahn on Wednesday.The first patient was treated with ProTrans in January 2018 and there are presently 4 clinical trials and one follow-up study ongoing. The active pharmaceutical ingredient in ProTrans is mesenchymal stromal cells from umbilical cord tissue. The patent pending selection algorithm is utilized for selection of cells and

Valmet and Circa to partner in the industrialization of sustainable biochemicals production

Valmet Oyj’s press release on May 24, 2022, at 11:00 a.m. EESTValmet has signed a Heads of Agreement with Circa to industrialize the production of sustainable biochemicals at Circa’s small-scale ReSolute plant in France and future large-scale production plants. Valmet will offer the main machinery and equipment and actively contribute to the development of Circa’s production processes of bio-based renewable solvents. The bio-based solvents will replace harmful petroleum-based solvents used in a wide variety of industries. “We are very pleased to join forces with Valmet. Cooperation will

Ahlsell Group acquires majority share in Sanistål A/S and submits a recommended offer for the remaining share

The acquisition of approximately 75.49% of the shares in Sanistål A/S from the majority owners and the simultaneously recommended public offering for the minority stake in Sanistål A/S, which was announced today, is an important step in Ahlsell’s ambition to be a comprehensive Nordic player with a complete offering also in Denmark. This is fully in line with Ahlsell’s strategy for sustainable growth.Sanistål is a Danish distributor and value-adding sourcing partner for businesses within construction and the industrial area. The company has a turnover of 3.5 BDKK and employs 1,200 people.

The threats to financial stability have increased

Inflation has risen rapidly in many countries, which is partly due to the aftermath of the pandemic in the form of disruptions in global supply chains and rising energy and commodity prices. Russia's invasion of Ukraine and lockdowns in China have contributed to a further rise in inflation. In response to this, central banks around the world have begun to conduct a less expansionary monetary policy, and interest rates have risen. It is uncertain how economic agents will manage higher interest rates. In Sweden, existing vulnerabilities have grown as a result of an increase in the debts of

SLP acquires ongoing construction project of logistics property

SLP has today, through a corporate transaction, acquired a logistics property in Halmstad with the designation Fyllinge 20:434. Construction of a logistics building is underway on the property, which will have a total lettable area of approximately 5,900 sqm. The tenant is Halmstads Delivery AB, which has a ten-year lease and will move in during the last quarter of 2022.Ownership of the properties will be transferred on 30 September 2022. The seller of the property is Kepada Gruppen AB, part of the ByggSjögren Group, and the transaction has taken place off-market. The underlying property

Invitation to Spinnova Investor Day 2022

SPINNOVA PLC, PRESS RELEASE, 24 MAY 2022 at 10:15 a.m. EEST Invitation to Spinnova Investor Day 2022 Spinnova invites investors and analysts to a virtual Investor Day on Tuesday, June 14th, 2022 from 2:30 p.m. until 5.30 p.m. The event will be held online. Institutional investors and analysts are offered the opportunity to participate live at the event with a site visit to the Spinnova factory and the Woodspin factory site in Jyväskylä. At the event, Spinnova’s executive management will provide information on the company’s growth strategy progress in three areas: technology

Respiratorius reports positive preclinical results for VAL001 for the indication relapsing DLBCL

Respiratorius announces that in a new in vitro study, valproate has shown improved inhibitory effects on cell growth, so-called antiproliferative effects, in combination with bendamustine, gemcitabine or carboplatin which are all cytotoxic substances used in the treatment of relapsing diffuse large cell B cell lymphoma (DLBCL).  A patent application for the new use of VAL001 has been filed.In newly diagnosed DLBCL, patients are primarily treated with chemotherapy that includes cyclophosphamide,doxorubicin, vincristine and prednisone (CHOP) in combination with immunotherapy, directed against

SelectImmune Pharma Interim report Q3 2021/2022

SELECTIMMUNE PHARMA IN SHORT · SelectImmune Pharma is an innovative biotech company, developing novel immunotherapies. · Excessive innate immune responses to infection cause symptoms and pathology in acute pyelonephritis and acute cystitis. Immunomodulation is therefore a realistic option for treating these conditions as alternatives or complements to antibiotics. · Several of the company’s drug candidates have shown protective effects against bacterial infection in animal models, including acute cystitis, severe kidney infection and urosepsis. · One drug candidate,

There are no items matching the current filter
There are no more items matching the current filter
Back to top